Payer+Provider's Health System Review
May 8, 2019
If pharmaceutical manufacturers are ashamed of their drug prices, then change the price, HHS Secretary Alex Azar says.
Precision medicine is a disruptive technology that is moving from revolution to evolution into mainstream adoption.
May 7, 2019
The share of physicians with ownership stakes in a medical practice declined 6 percent, driven largely by younger physicians.
May 6, 2019
An estimated 2 percent of the increase will be due to the return on the health insurance tax.
Physicians need to work at seeking feedback from patients and meaningfully incorporating patient preferences into treatment plans.
Prices for the drugs, which range from diabetes medications to antivirals to immunosuppressants, were 3.2 to 4.1 times higher in the U.S.
The nature of acquisitions is changing, with less volume but more high-dollar deals — many of them focused on population health.
May 3, 2019
The cost increases from other aspects of patient care cancel out the induction-related costs, contradicting long-held assumptions.
The actions represent components of a strategy to address barriers to medical innovation in the Medicare program.